This site is intended for healthcare professionals only
LoginRegister
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDCZydus Gets SEC Nod to Begin Phase IV Trial of Dydrogesterone ER for Habitual Miscarriage
NPPA Finally Allows GSK to Discontinue Grisovin FPCDSCO Panel Approves GSK's Proposal to Double Indian Patient Pool in Dostarlimab Trial
Aurobindo Pharma Gets USFDA Nod for Generic Ravicti to Treat Urea Cycle DisordersAurobindo Pharma to manufacture, supply HIV treatment cabotegravir across 133 countries
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusZydus Lifesciences bags USFDA okay for Celecoxib Capsules for juvenile rheumatoid arthritis...
MerckMerck to begin Phase 3 trials for investigational once monthly HIV prevention pill
USFDA Expands Use of GSKs RSV Vaccine Arexvy to Adults 18-49 at RiskGSK application for expanded RSV vaccine Arexvy use for adults 18-49 accepted for review by USFDA
KGMU Doctor Remanded as Police Probe Alleged Sexual Exploitation Across UPSecond arrest made in Telangana counterfeit 'Levipil 500' case
Bayer Finerenone approved in Japan for chronic heart failureBayer gets USFDA nod for Finerenone for new indication in heart failure patients
foreign-qualified woman doctor shot deadDeadly blast in Telangana: Death toll hits 45
Health Ministry Proposes Notification-Based Approval for Pharma Export BE Studies Instead of Central Licensing Authority NodDo Not Issue Licenses Without New Drug Permission from DCGI, Govt Panel Tells States
AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer TrialAstraZeneca Pharma India receives CDSCO nod for expanded use of Imfinzi in bladder cancer
No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUNSun Pharma unveils Leqselvi in US for severe Alopecia Areata
X